The first large-scale trial of an experimental Ebola vaccine has begun in Liberia.
Large-scale vaccine trial begins in Liberia
About 30,000 people are expected to be injected with the experimental vaccine starting from Monday, February 2.
Recommended articles
About 30,000 people are expected to be injected with the drug starting from Monday, February 2.
The subjects, which include health workers and volunteers, will be administered with a small amount of the vaccine which carries safe genetic material of Ebola, tricking the human body into producing an immune response.
The trial is being conducted as part of a partnership between Liberia and the US.
ADVERTISEMENT
Liberian Vice President, Joseph Nyumah Boakai told The Associated Press that the vaccines are "very important for Liberia and for the world."
The vaccine was developed by British pharmaceutical giant, GlaxoSmithKline in conjunction with the U.S. National Institutes of Health.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
Recommended articles
National Assembly to make law that'll make university admission illegal for under 18
Ganduje describes his purported suspension from APC as African drama
Minister of Education summons Lead British School management over bullying scandal
Coalition backs Tinubu's policies, security interventions, other reforms
Kano ranked as worst-governed state in Nigeria
EFCC boss vows to resign if Yahaya Bello is not prosecuted
EFCC arrests ex-aviation minister Sirika for ₦8bn Nigerian Air scandal
Ex-APC spokesperson backs EFCC's hunt for Yahaya Bello
Woman suffering incurable disease finally gets her wish to choose how she dies
ADVERTISEMENT
